Case number 2015-1700
Braintree Laboratories, Inc. v. Lupin Atlantis Holdings SA > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Sep 30, 2016 | 94 | Mandate issued to the United States District Court for the District of New Jersey. Service as of this date by Clerk of Court. [370392] [JCA] [Entered: 09/30/2016 09:00 AM] (1) |
| Sep 9, 2016 | 93 | Status report for Appellant Lupin Atlantis Holdings SA and Appellee Braintree Laboratories, Inc.. Service: 09/09/2016 by email. [365630] [Patrick Kilgore] [Entered: 09/09/2016 04:53 PM] (5) |
| Aug 24, 2016 | 92 | ORDER filed granting motion for remand to the district court [91] filed by Appellee Braintree Laboratories, Inc. and Appellant Lupin Atlantis Holdings SA. By: (Per Curiam). Service as of this date by Clerk of Court. [361463] [SJ] [Entered: 08/24/2016 08:47 AM] (2) |
| Aug 22, 2016 | 91 | MOTION of Appellant Lupin Atlantis Holdings SA and Appellee Braintree Laboratories, Inc. for limited remand. Response/Opposition is due 09/06/2016 [Consent: unopposed]. Service: 08/22/2016 by email. [360864] [Patrick Kilgore] [Entered: 08/22/2016 02:46 PM] (6) |
| Aug 10, 2016 | 90 | ORDER filed granting motion to stay appeal [89] filed by Appellee Braintree Laboratories, Inc. and Appellant Lupin Atlantis Holdings SA. By: Merits Panel (Per Curiam). Service as of this date by Clerk of Court. [357787] [MJL] [Entered: 08/10/2016 04:04 PM] (2) |
| Aug 5, 2016 | 89 | MOTION of Appellant Lupin Atlantis Holdings SA and Appellee Braintree Laboratories, Inc. to stay appeal. Response/Opposition is due 08/18/2016 [Consent: unopposed]. Service: 08/05/2016 by email. [356643] [Patrick Kilgore] [Entered: 08/05/2016 06:03 PM] (7) |
| Jul 21, 2016 | 88 | NOTICE OF CALENDARING. Panel: 1609F. Case scheduled Sep 09, 2016 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, N.W. Washington, DC 20439), Courtroom 201. Response to oral argument order due: 08/15/2016. Counsel should check-in 30 minutes prior to the opening of the session. Please review the Oral Argument Order. [352581] THIS NOTICE APPLIES TO CASE(S): [15-1700, 15-1808, 15-1960, 15-1968] [JAB] [Entered: 07/21/2016 11:43 AM] (0) |
| Jul 11, 2016 | 87 | ORDER filed. The motion [85] is granted. The revised official caption and short caption are reflected in the order. Service: 07/11/2016 by clerk. [349856] [LMS] [Entered: 07/11/2016 03:13 PM] (2) |
| Jul 11, 2016 | 86 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: Notice regarding the ECF account of Mr. H. Keeto Sabharwal, Esq. for Novel Laboratories, Inc. The e-mail address associated with your CM/ECF account has generated a delivery failure notice. Pursuant to Fed. Cir. R. 47.3(c)(1), counsel should promptly update his account information with the Pacer Service Center. If the attorney is no longer associated with the case, counsel should promptly move to withdraw the attorney (see Fed. Cir. R. 47.3(c)(5)). [349604] [IW] [Entered: 07/11/2016 08:21 AM] (0) |
| Jul 7, 2016 | 85 | MOTION of Appellant Novel Laboratories, Inc. to substitute party. Response/Opposition is due 07/21/2016 [Consent: unopposed]. Service: 07/07/2016 by email. [349190] [Patrick Kilgore] [Entered: 07/07/2016 05:47 PM] (8) |
| May 13, 2016 | 84 | Notice from Appellant Novel Laboratories, Inc. regarding conflicts with oral argument (July 5-8). Service: 05/13/2016 by email. [334951] [Patrick Kilgore] [Entered: 05/13/2016 02:19 PM] (3) |
| May 13, 2016 | 83 | Notice from Appellee Braintree Laboratories, Inc. regarding conflicts with oral argument (August 1-5, 2016). Service: 05/13/2016 by email. [334945] [John Regan] [Entered: 05/13/2016 02:00 PM] (3) |
| May 11, 2016 | 82 | Clerk's Letter to Appellant Novel Laboratories, Inc. and Appellee Braintree Laboratories, Inc. (Clerk's letter to parties regarding oral argument scheduling conflicts). See related entry: [81], [80]. Service as of this date by Clerk of Court. Response due on or before 05/13/2016. [334131] [JAB] [Entered: 05/11/2016 11:44 AM] (2) |
| May 9, 2016 | 81 | Notice from Appellant Novel Laboratories, Inc. regarding conflicts with oral argument (See letter; July 5-8; October 3-7; October 31 - November 4). Service: 05/09/2016 by email. [333431] [Patrick Kilgore] [Entered: 05/09/2016 03:48 PM] (3) |
| May 9, 2016 | 80 | Notice from Appellee Braintree Laboratories, Inc. regarding conflicts with oral argument (August 1-5, 2016). Service: 05/09/2016 by email. [333149] [John Regan] [Entered: 05/09/2016 09:21 AM] (3) |
| May 5, 2016 | 79 | Notice from Appellant Novel Laboratories, Inc. regarding conflicts with oral argument (July 5-8; October 3-7; October 31 - November 4). Service: 05/05/2016 by email. [332551] [Patrick Kilgore] [Entered: 05/05/2016 03:16 PM] (2) |
| May 5, 2016 | 78 | Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks [JULY, AUG, SEPT], or thereafter if conflicts are known. When filing the notice of conflicts, counsel should docket the Notice of Conflict with Argument Dates event, which is found in the Calendar event category.. [332372] [AT] [Entered: 05/05/2016 09:04 AM] (0) |
| May 4, 2016 | 77 | ORDER filed. The motion [72] is denied as moot. Service: 05/04/2016 by clerk. [332244] [LMS] [Entered: 05/04/2016 03:16 PM] (2) |
| Apr 28, 2016 | 76 | Entry of appearance for Robert F. Vroom as of counsel for Breckenridge Pharmaceutical, Inc.. Service: 04/28/2016 by email. [330534] [Robert Vroom] [Entered: 04/28/2016 05:21 PM] (2) |
| Apr 28, 2016 | 75 | Entry of appearance for Jennifer P. Nock as of counsel for Breckenridge Pharmaceutical, Inc.. Service: 04/28/2016 by email. [330533] [Jennifer Nock] [Entered: 04/28/2016 05:18 PM] (2) |
| Apr 28, 2016 | 74 | Entry of appearance for Lisa N. Phillips as of counsel for Breckenridge Pharmaceutical, Inc.. Service: 04/28/2016 by email. [330531] [Lisa Phillips] [Entered: 04/28/2016 05:12 PM] (2) |
| Apr 28, 2016 | 73 | TENDERED from Breckenridge Pharmaceutical, Inc. Title: AMICUS CURIAE BRIEF. Service: 04/28/2016 by email. [330530] [Steven Lieberman] [Entered: 04/28/2016 05:08 PM] (0) |
| Apr 28, 2016 | 72 | MOTION of Breckenridge Pharmaceutical, Inc. for leave to file an amicus curiae brief. Response/Opposition is due 05/12/2016 [Consent: opposed]. Service: 04/28/2016 by email. [330527] [Steven Lieberman] [Entered: 04/28/2016 05:05 PM] (9) |
| Apr 28, 2016 | 71 | Entry of appearance for Steven M. Lieberman as principal counsel for Breckenridge Pharmaceutical, Inc.. Service: 04/28/2016 by email. [330525] [Steven Lieberman] [Entered: 04/28/2016 05:00 PM] (2) |
| Apr 28, 2016 | 70 | ORDER filed. The motion [65] is denied. Service: 04/28/2016 by clerk. [330388] [LMS] [Entered: 04/28/2016 02:51 PM] (2) |
| Apr 27, 2016 | 69 | REPLY of Appellant Novel Laboratories, Inc. to response filed by Appellee in 15-1700 , Doc. No [68]. Service: 04/27/2016 by email. [330040] [Patrick Kilgore] [Entered: 04/27/2016 02:17 PM] (14) |
| Apr 25, 2016 | 68 | RESPONSE of Appellee Braintree Laboratories, Inc. to the motion to stay appeal [65] filed by Appellant Novel Laboratories, Inc. in 15-1700 , motion to schedule oral argument [65] filed by Appellant Novel Laboratories, Inc. in 15-1700 , motion to reschedule argument [65] filed by Appellant Novel Laboratories, Inc. in 15-1700. Service: 04/25/2016 by email. [329445] [John Regan] [Entered: 04/25/2016 05:10 PM] (13) |
| Apr 21, 2016 | 67 | ORDER filed. Any opposition to the motion [65] is due no later than April 25, 2016. Any reply in support of the motion is due no later than three days thereafter. Service: 04/21/2016 by clerk. [328444] [LMS] [Entered: 04/21/2016 12:47 PM] (2) |
| Apr 18, 2016 | 66 | Notice from Appellee Braintree Laboratories, Inc. Intent to Oppose Novel's Motion to Stay this Appeal or Postpone Oral Argument. Service: 04/18/2016 by email. [327186] [John Regan] [Entered: 04/18/2016 03:28 PM] (6) |
| Apr 15, 2016 | 65 | MOTION of Appellant Novel Laboratories, Inc. to stay appeal or in the alternative to reschedule oral argument. Response/Opposition is due 04/28/2016 [Consent: not addressed]. Service: 04/15/2016 by email. [326763]--[ENTRY EDITED BY THE CLERK 04/15/2016 by AT - Reason: to correct the relief to "reschedule" oral argument] [Patrick Kilgore] [Entered: 04/15/2016 02:38 PM] (26) |
| Mar 15, 2016 | 64 | Amended Certificate of Interest for the Appellant Novel Laboratories, Inc.. Service: 03/15/2016 by email. [318911] [Patrick Kilgore] [Entered: 03/15/2016 04:10 PM] (2) |
| Feb 24, 2016 | 63 | Notice from Appellee Braintree Laboratories, Inc. regarding conflicts with oral argument (May 2-6, 2016). Service: 02/24/2016 by email. [313576] [John Regan] [Entered: 02/24/2016 11:27 AM] (2) |
| Feb 19, 2016 | 62 | Notice from Appellant Novel Laboratories, Inc. regarding conflicts with oral argument (March 14-18; June 6-17; June 20 - July 1; September 26 - October 4; October 19 - November 18). Service: 02/19/2016 by email. [312499] [Patrick Kilgore] [Entered: 02/19/2016 03:20 PM] (2) |
| Feb 11, 2016 | 61 | Notice from Appellee Braintree Laboratories, Inc. regarding conflicts with oral argument (April 7 and April 8, 2016). Service: 02/11/2016 by email. [310289] [John Regan] [Entered: 02/11/2016 11:18 AM] (2) |
| Feb 9, 2016 | 60 | 6 paper copies (each) of the 3 Volume Appendix [58] received from Appellant Novel Laboratories, Inc.. [309939] [LAJ] [Entered: 02/10/2016 11:34 AM] (0) |
| Feb 5, 2016 | 59 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a), Fed. Cir. R. 47.3 and ECF-2(E) to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [308857] [AT] [Entered: 02/05/2016 12:08 PM] (0) |
| Feb 4, 2016 | 58 | CONFIDENTIAL JOINT APPENDIX FILED for Novel Laboratories, Inc. [55]. Number of Pages: 1059. Service: 02/04/2016 by email. Pursuant to ECF-10 six paper copies should be filed of the confidential version only. [308853] [AT] [Entered: 02/05/2016 12:06 PM] (0) |
| Feb 4, 2016 | 57 | APPENDIX FILED for Novel Laboratories, Inc. [56]. Number of Pages: 1059. Service: 02/04/2016 by email. Pursuant to ECF-10, filer is directed to file six copies of the confidential version of the appendix in paper format. The paper copies should be received by the court on or before 02/10/2016. [308850] [AT] [Entered: 02/05/2016 12:03 PM] (1059) |
| Feb 4, 2016 | 56 | TENDERED from Appellant Novel Laboratories, Inc.. Title: JOINT APPENDIX. Service: 02/04/2016 by email. [308644] [Deanne Mazzochi] [Entered: 02/04/2016 03:50 PM] (1059) |
| Feb 4, 2016 | 55 | TENDERED from Appellant Novel Laboratories, Inc.. Title: CONFIDENTIAL JOINT APPENDIX Service: 02/04/2016 by email. [308627] [Deanne Mazzochi] [Entered: 02/04/2016 03:34 PM] (0) |
| Jan 29, 2016 | 54 | 6 paper copies of the Reply Brief [52] received from Appellant Novel Laboratories, Inc.. [307592] [MJL] [Entered: 02/01/2016 04:28 PM] (0) |
| Jan 28, 2016 | 53 | Statement of Compliance with Fed. Cir. R. 33 for Appellant Novel Laboratories, Inc. and Appellee Braintree Laboratories, Inc.. Service: 01/28/2016 by email. [306855] [Patrick Kilgore] [Entered: 01/28/2016 05:17 PM] (4) |
| Jan 26, 2016 | 52 | REPLY BRIEF FILED for Appellant Novel Laboratories, Inc. [51]. Number of Pages: 34. Service: 01/25/2016 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 02/01/2016. Appendix is due 02/04/2016. [305978] [AT] [Entered: 01/27/2016 12:12 PM] (44) |
| Jan 26, 2016 | 51 | TENDERED from Appellant Novel Laboratories, Inc.. Title: REPLY BRIEF. Service: 01/25/2016 by email. [305645] [Deanne Mazzochi] [Entered: 01/25/2016 05:53 PM] (44) |
| Nov 25, 2015 | 48 | Amended Entry of appearance for William A. Rakoczy as principal counsel for Appellant Novel Laboratories, Inc.. Service: 11/25/2015 by email. [291805] [Patrick Kilgore] [Entered: 11/25/2015 10:55 AM] (2) |
| Nov 25, 2015 | 47 | **TEXT ONLY** ORDER granting motion to substitute attorney [45] filed by Appellant Novel Laboratories, Inc. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [291772] [JW] [Entered: 11/25/2015 10:13 AM] (0) |
| Nov 25, 2015 | 49 | 6 paper copies of the Opening Response Brief [38] received from Appellee Braintree Laboratories, Inc.. [291896] [MJL] [Entered: 11/25/2015 01:49 PM] (0) |
| Nov 25, 2015 | 50 | **TEXT ONLY** ORDER granting motion to extend time to file reply brief [46] filed by Appellant Novel Laboratories, Inc. Reply brief is due 01/25/2016. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [291957] [SJ] [Entered: 11/25/2015 03:12 PM] (0) |
| Nov 24, 2015 | 46 | MOTION of Appellant Novel Laboratories, Inc. to extend the time to 01/25/2016 to file the reply brief. Response/Opposition is due 12/07/2015 [Consent: unopposed]. Service: 11/24/2015 by email. [291694] [Patrick Kilgore] [Entered: 11/24/2015 06:10 PM] (6) |
| Nov 24, 2015 | 45 | MOTION of Appellant Novel Laboratories, Inc. to substitute attorney. Response/Opposition is due 12/07/2015 [Consent: unopposed]. Service: 11/24/2015 by email. [291692] [Patrick Kilgore] [Entered: 11/24/2015 05:46 PM] (4) |
| Nov 24, 2015 | 44 | Amended Certificate of Interest for the Appellant Novel Laboratories, Inc.. Service: 11/24/2015 by email. [291690] [Patrick Kilgore] [Entered: 11/24/2015 05:40 PM] (2) |
| Nov 24, 2015 | 43 | Entry of appearance for Patrick C. Kilgore as of counsel for Appellant Novel Laboratories, Inc.. Service: 11/24/2015 by email. [291689] [Patrick Kilgore] [Entered: 11/24/2015 05:37 PM] (2) |
| Nov 24, 2015 | 42 | Entry of appearance for Peter J. Curtin as of counsel for Appellant Novel Laboratories, Inc.. Service: 11/24/2015 by email. [291688] [Patrick Kilgore] [Entered: 11/24/2015 05:35 PM] (2) |
| Nov 24, 2015 | 41 | Entry of appearance for Deanne M. Mazzochi as of counsel for Appellant Novel Laboratories, Inc.. Service: 11/24/2015 by email. [291686] [Patrick Kilgore] [Entered: 11/24/2015 05:34 PM] (2) |
| Nov 24, 2015 | 40 | Entry of appearance for Paul J. Molino as of counsel for Appellant Novel Laboratories, Inc.. Service: 11/24/2015 by email. [291684] [Patrick Kilgore] [Entered: 11/24/2015 05:33 PM] (2) |
| Nov 24, 2015 | 39 | Entry of appearance for William A. Rakoczy as of counsel for Appellant Novel Laboratories, Inc.. Service: 11/24/2015 by email. [291683] [Patrick Kilgore] [Entered: 11/24/2015 05:31 PM] (2) |
| Nov 23, 2015 | 38 | BRIEF FILED for Appellee Braintree Laboratories, Inc. [37]. Number of Pages: 68. Service: 11/23/2015 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 11/30/2015. Appellant Novel Laboratories, Inc. reply brief is due 12/10/2015. [291289] [JCA] [Entered: 11/24/2015 09:08 AM] (77) |
| Nov 23, 2015 | 37 | TENDERED from Appellee Braintree Laboratories, Inc.. Title: OPENING BRIEF. Service: 11/23/2015 by email. [291241] [John Regan] [Entered: 11/23/2015 08:21 PM] (77) |
| Oct 6, 2015 | 36 | **TEXT ONLY** ORDER granting motion to extend time to file appellee/respondent/cross-appellant principal brief [35] filed by Appellee Braintree Laboratories, Inc. Appellee Braintree Laboratories, Inc. brief due 11/23/2015. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [278180] [LN] [Entered: 10/06/2015 03:57 PM] (0) |
| Oct 5, 2015 | 35 | MOTION of Appellee Braintree Laboratories, Inc. to extend the time to 11/23/2015 at 11:59 pm to file the appellee/respondent/cross-appellant's principal brief. Response/Opposition is due 10/19/2015 [Consent: unopposed]. Service: 10/05/2015 by email. [277638] [John Regan] [Entered: 10/05/2015 03:34 PM] (9) |
| Sep 14, 2015 | 34 | 6 paper copies of the Opening Brief [33] received from Appellant Novel Laboratories, Inc.. [271997] [LAJ] [Entered: 09/14/2015 04:04 PM] (0) |
| Sep 9, 2015 | 33 | BRIEF FILED for Appellant Novel Laboratories, Inc. [32]. Number of Pages: 47. Service: 09/09/2015 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 09/16/2015. Appellee Braintree Laboratories, Inc. brief is due 10/22/2015. [271284] [LN] [Entered: 09/11/2015 09:16 AM] (98) |
| Sep 9, 2015 | 32 | TENDERED from Appellant Novel Laboratories, Inc.. Title: OPENING BRIEF. Service: 09/09/2015 by email. [270795] [H. Sabharwal] [Entered: 09/09/2015 09:25 PM] (98) |
| Jul 31, 2015 | 31 | ORDER granting motion to extend time to file appellant's principal brief [30] filed by Appellant Novel Laboratories, Inc. Brief due 09/09/2015. Service as of this date by Clerk of Court. [261062] [AT] [Entered: 07/31/2015 10:18 AM] (2) |
| Jul 30, 2015 | 30 | MOTION of Appellant Novel Laboratories, Inc. to extend the time to 09/09/2015 at 11:59 pm to file the appellant/petitioner's principal brief. Response/Opposition is due 08/13/2015 [Consent: unopposed]. Service: 07/30/2015 by email. [260875] [Byron Pickard] [Entered: 07/30/2015 05:56 PM] (9) |
| Jul 20, 2015 | 29 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellant Novel Laboratories, Inc.. Service: 07/20/2015 by email. [257578] [Oren Langer] [Entered: 07/20/2015 11:19 AM] (3) |
| Jul 17, 2015 | 28 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellee Braintree Laboratories, Inc.. Service: 07/17/2015 by email. [257382] [John Regan] [Entered: 07/17/2015 03:47 PM] (4) |
| Jun 29, 2015 | 27 | ORDER reactivating case. Appellant's brief is due on August 10, 2015. Service as of this date by Clerk of Court. [252132] [AT] [Entered: 06/29/2015 01:13 PM] (2) |
| Jun 25, 2015 | 26 | Notice from Appellee Braintree Laboratories, Inc. regarding postjudgment motions. Service: 06/25/2015 by email. [251620] [John Regan] [Entered: 06/25/2015 05:30 PM] (6) |
| Jun 22, 2015 | 25 | ORDER deactivating appeal. Service as of this date by Clerk of Court. [250223] [AT] [Entered: 06/22/2015 08:27 AM] (2) |
| Jun 19, 2015 | 24 | Notice from Appellee Braintree Laboratories, Inc. regarding postjudgment motions. Service: 06/19/2015 by email. [250135] [John Regan] [Entered: 06/19/2015 05:11 PM] (23) |
| Jun 19, 2015 | 23 | Corrected Entry of appearance for Ronald J. Schutz as of counsel for Appellant Novel Laboratories, Inc.. Service: 06/19/2015 by email. [250037] [Ronald Schutz] [Entered: 06/19/2015 03:21 PM] (2) |
| Jun 19, 2015 | 22 | Corrected Entry of appearance for Oren D. Langer as of counsel for Appellant Novel Laboratories, Inc.. Service: 06/19/2015 by email. [250033] [Oren Langer] [Entered: 06/19/2015 03:18 PM] (2) |
| Jun 19, 2015 | 21 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:attorney entry of appearance [RONALD DAIGNAULT] Docket No. [20], ERROR: Appellant's counsel RONALD DAIGNAULT's entry of appearance reflects a different law firm affiliation than his registered ECF filer account. Mr. Daignault's current law firm affiliation in ECF is Robins Kaplan Miller & Ciresi LLP. CORRECTION: Counsel DAIGNAULT should update his ECF account ASAP with his current firm affiliation & contact information. Go to www.pacer.gov "manage my appellate filer account". THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [249907] [AT] [Entered: 06/19/2015 11:50 AM] (0) |
| Jun 19, 2015 | 20 | Corrected Entry of appearance for Ronald M. Daignault as of counsel for Appellant Novel Laboratories, Inc.. Service: 06/19/2015 by email. [249863] [Ronald Daignault] [Entered: 06/19/2015 10:24 AM] (2) |
| Jun 19, 2015 | 19 | NOTICE OF DEFICIENCY: The attorney entries of appearance for OREN LANGER, RONALD DAIGNAULT, RONALD SCHUTZ Document Nos. [6] [10] [18] filed by Appellant Novel Laboratories, Inc. in 15-1700 are not text searchable and therefore cannot be accepted for filing at this time. You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [249823] [AT] [Entered: 06/19/2015 08:39 AM] (0) |
| Jun 18, 2015 | 18 | Entry of appearance for Ronald M. Daignault as of counsel for Appellant Novel Laboratories, Inc.. Service: 06/18/2015 by email. [249766] [Ronald Daignault] [Entered: 06/18/2015 04:42 PM] (0) |
| Jun 18, 2015 | 17 | Docketing Statement for the Appellee Braintree Laboratories, Inc.. Service: 06/18/2015 by email. [249733] [John Regan] [Entered: 06/18/2015 03:53 PM] (5) |
| Jun 18, 2015 | 16 | Certificate of Interest for the Appellee Braintree Laboratories, Inc.. Service: 06/18/2015 by email. [249732] [John Regan] [Entered: 06/18/2015 03:51 PM] (1) |
| Jun 18, 2015 | 15 | Entry of appearance for Michael A. Greene as of counsel for Appellee Braintree Laboratories, Inc.. Service: 06/18/2015 by email. [249730] [Michael Greene] [Entered: 06/18/2015 03:50 PM] (1) |
| Jun 18, 2015 | 14 | Entry of appearance for Anna E. Lumelsky as of counsel for Appellee Braintree Laboratories, Inc.. Service: 06/18/2015 by email. [249728] [Anna Lumelsky] [Entered: 06/18/2015 03:48 PM] (1) |
| Jun 18, 2015 | 13 | Entry of appearance for Mark C. Fleming as of counsel for Appellee Braintree Laboratories, Inc.. Service: 06/18/2015 by email. [249727] [Mark Fleming] [Entered: 06/18/2015 03:46 PM] (1) |
| Jun 18, 2015 | 12 | Entry of appearance for Christopher R. Noyes as of counsel for Appellee Braintree Laboratories, Inc.. Service: 06/18/2015 by email. [249726] [Christopher Noyes] [Entered: 06/18/2015 03:45 PM] (1) |
| Jun 18, 2015 | 11 | Entry of appearance for John J. Regan as principal counsel for Appellee Braintree Laboratories, Inc.. Service: 06/18/2015 by email. [249722] [John Regan] [Entered: 06/18/2015 03:43 PM] (1) |
| Jun 18, 2015 | 10 | Corrected Entry of appearance for Ronald J. Schutz as of counsel for Appellant Novel Laboratories, Inc.. Service: 06/18/2015 by email. [249675] [Ronald Schutz] [Entered: 06/18/2015 02:21 PM] (0) |
| Jun 18, 2015 | 9 | Docketing Statement for the Appellant Novel Laboratories, Inc.. Service: 06/18/2015 by email. [249671] [Matthew McFarlane] [Entered: 06/18/2015 02:17 PM] (5) |
| Jun 18, 2015 | 8 | Certificate of Interest for the Appellant Novel Laboratories, Inc.. Service: 06/18/2015 by email. [249670] [Matthew McFarlane] [Entered: 06/18/2015 02:16 PM] (3) |
| Jun 18, 2015 | 7 | Entry of appearance for Matthew B. McFarlane as of counsel for Appellant Novel Laboratories, Inc.. Service: 06/18/2015 by email. [249669] [Matthew McFarlane] [Entered: 06/18/2015 02:15 PM] (2) |
| Jun 18, 2015 | 6 | Entry of appearance for Oren D. Langer as of counsel for Appellant Novel Laboratories, Inc.. Service: 06/18/2015 by email. [249668] [Oren Langer] [Entered: 06/18/2015 02:14 PM] (0) |
| Jun 18, 2015 | 5 | Entry of appearance for Ronald J. Schutz as of counsel for Appellant Novel Laboratories, Inc.. Service: 06/18/2015 by email. [249664] [Ronald Schutz] [Entered: 06/18/2015 02:01 PM] (1) |
| Jun 18, 2015 | 4 | Entry of appearance for Nirav N. Desai as of counsel for Appellant Novel Laboratories, Inc.. Service: 06/18/2015 by email. [249627] [Nirav Desai] [Entered: 06/18/2015 12:42 PM] (2) |
| Jun 18, 2015 | 3 | Entry of appearance for Byron L. Pickard as of counsel for Appellant Novel Laboratories, Inc.. Service: 06/18/2015 by email. [249625] [Byron Pickard] [Entered: 06/18/2015 12:39 PM] (2) |
| Jun 18, 2015 | 2 | Entry of appearance for H. Keeto Sabharwal as principal counsel for Appellant Novel Laboratories, Inc.. Service: 06/18/2015 by email. [249623] [H. Sabharwal] [Entered: 06/18/2015 12:36 PM] (2) |
| Jun 4, 2015 | 1 | Appeal docketed. Received: 06/04/2015. [245920]Entry of Appearance due 06/18/2015. Certificate of Interest is due on 06/18/2015. Docketing Statement due 06/18/2015. Appellant's brief is due 08/03/2015. [AT] [Entered: 06/04/2015 01:01 PM] (92) |
